Cargando…

Differential Expression of miRNA-223 in Coronary In-Stent Restenosis

Objective: In-stent restenosis (ISR) is an unfavorable complication that occurs in patients after coronary stenting. Despite the progress with advent of modern DES and new antiplatelet agents, restenosis still hampers PCI short- and long-term results. The aim of this study was to investigate whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ganjali, Shiva, Aghaee-Bakhtiari, Seyed Hamid, Reiner, Željko, Sahebkar, Amirhossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836934/ https://www.ncbi.nlm.nih.gov/pubmed/35160300 http://dx.doi.org/10.3390/jcm11030849

Ejemplares similares

Compositional and functional properties of high-density lipoproteins in relation to coronary in-stent restenosis
por: Ganjali, Shiva, et al.
Publicado: (2021)

Association between Oxidative Burden and Restenosis: A Case-Control Study
por: Ganjali, Shiva, et al.
Publicado: (2022)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation
por: McDonald, Robert A., et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Predictive value of miRNA-126 on in-stent restenosis in patients with coronary heart disease: A protocol for meta-analysis and bioinformatics analysis
por: Qiu, Xianke, et al.
Publicado: (2021)

Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2021)

miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease
por: Schulte, Christian, et al.
Publicado: (2015)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Heavy Coronary Calcium Mimicking In-Stent Restenosis
por: Park, Jeong-Hwan, et al.
Publicado: (2011)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2022)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Associations of miRNA-146a and miRNA-223 with Rheumatoid Arthritis and Their Predictive Values
por: Zhang, Haoshaqiang, et al.
Publicado: (2023)

Diagnostic value of intraluminal stent enhancement in estimating coronary in-stent restenosis
por: Nogourani, Mehdi Karami, et al.
Publicado: (2020)

MiR-93-5p is a novel predictor of coronary in-stent restenosis
por: O'Sullivan, John F, et al.
Publicado: (2019)

Coated stents to prevent restenosis in coronary heart disease
por: Gorenoi, Vitali, et al.
Publicado: (2005)

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis
por: Lekshmi, Kamali Manickavasagam, et al.
Publicado: (2017)

Treatment of coronary in-stent restenosis: a systematic review
por: Pleva, Leos, et al.
Publicado: (2018)

Diagnosis and management challenges of in-stent restenosis in coronary arteries
por: Alraies, M Chadi, et al.
Publicado: (2017)

‘Miracle stents’ - a future without restenosis
por: Hamid, Huda, et al.
Publicado: (2007)

Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone
por: Ganjali, Shiva, et al.
Publicado: (2020)

miRNA-92a inhibits vascular smooth muscle cell phenotypic modulation and may help prevent in-stent restenosis
por: Jiang, Fenfen, et al.
Publicado: (2023)

Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective
por: McDowell, Garry, et al.
Publicado: (2011)

Impact of anemia on in-stent restenosis after percutaneous coronary intervention
por: Hu, Huilin, et al.
Publicado: (2021)

Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management
por: Abouelnour, Amr, et al.
Publicado: (2022)

miRNA-223 is a potential diagnostic and prognostic marker for osteosarcoma
por: Dong, Junbo, et al.
Publicado: (2016)

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia
por: Ganjali, Shiva, et al.
Publicado: (2023)

The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
por: Ataei, Sarina, et al.
Publicado: (2023)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

miR-30b-5p Downregulation as a Predictive Biomarker of Coronary In-Stent Restenosis
por: Gutierrez-Carretero, Encarnación, et al.
Publicado: (2021)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
por: Yin, Rui-Xing, et al.
Publicado: (2014)

Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)

Coronary Angioscopy Findings before and after Excimer Laser Coronary Angioplasty for Bare-Metal Stent In-Stent Restenosis
por: Masuda, Shinichiro, et al.
Publicado: (2019)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8fg69vhkel43gapk6ms9tcgl07